
From Our Web Site
Biotech Community Called to Support NBAF Bid
North Carolina's bid to land the $450 million National Bio and Agro-Defense Facility (NBAF) could use a boost from the state's biotechnology community on Sept. 18 when the federal government hosts a public meeting.
BioDelivery Sciences Acquires Drug Delivery System
BioDelivery Sciences International (Morrisville) exercised an option to acquire the U.S. rights to QLT USA's (Fort Collins, CO) drug delivery technology.
NanoCor Brings in $3.75M for Heart Research
Medtronic of Minneapolis made a $3.75 million investment in NanoCor Therapeutics (Chapel Hill). Medtronic receives certain rights to exclusively license NanoCor's treatment for congestive heart failure.
Pozen Medication Enters Phase III
The drug candidate, PN 400, also is the subject of a revised deal with AstraZeneca, which could total up to $345 million for Pozen.
In Focus
Strategic Plan Targets Advanced Medical Technologies
By Jim Shamp,
News and Publications Editor
Advanced medical technologies represent a fast-growing business sector ripe for plucking by North Carolina’s academic and business community.
That's the conclusion of a strategic plan unveiled Wednesday by the North Carolina Biotechnology Center. And the document challenges business, academic and civic leaders statewide to get behind establishment of a North Carolina Center for Advanced Medical Technologies.
News From Other Sites
Durham Biotech Raises $9M
"Biotech company Aldagen has closed on an extra $9 million in series C funding. The extra funding, which comes on top of the $14.3 million in venture cash the Durham company closed on in December, is enough to take Aldagen's three pipeline drugs through trials until mid-2009, said Chief Operating Officer Ed Field."
From The Triangle Business Journal
Bent Creek Institute to Study Traditional Plant Remedies
"BENT CREEK – For centuries, the Cherokee Indians looked to the rich forests of Western North Carolina as their medicine cabinet, harvesting native plants to treat a variety of ailments."
From The Asheville Citizen-Times
Biotechnology Center Calls for More Coordinated Support of Growing Medical-Device Industry
"North Carolina's business, academic and medical communities should work together to better develop the state's growing medical-device industry, according to a state report released Wednesday."
From The Winston-Salem Journal
Companies Help Entrepreneurs on Design, Marketing
"According to the N.C. Biotechnology Center, there were about 142 medical-device companies in North Carolina last year, a 35 percent increase from 1996. The state’s industry is forecast to grow to a $9.5 billion market in 2009."
From The Winston-Salem Journal
North Carolina Without the Biotechnology Center and MCNC. Where Would We Be?
"As (Biotechnology Center President and CEO) Norris Tolson spoke, I couldn't help but think about what North Carolina would be like today if some far-sighted individuals led by former Gov.Jim Hunt had not taken the risk of creating the Biotechnology Center, MCNC and other efforts that have become crucial components for the state's technology community."
From WRAL LocalTechWire.com
Community Watch
Events Calendar
Sept. 17
Biotech Forum: Meet The New Companies (Research Triangle Park)
Sept. 18
NBAF Public Meeting (Creedmoor)
Sept. 20
BPD Seminar (Research Triangle Park)
Bioprospecting, Nutrisciences And Therapeutic Applications Luncheon (Research Triangle Park)
Sept. 25
SBIR Seminar (Greenville)
Sept. 28
2007 Plant Molecular Biology Retreat (Wrightsville Beach)
NC OPT-ED Alliance Day (Greensboro)
Biotechnology and the Culture Wars: Bioethics at the Center (Charlotte)
Save the Date
Oct. 10
Southeastern BIO Investor Forum (Pinehurst)
Oct. 12
Sixth Annual Charlotte Biotechnology Conference (Charlotte)
Nov. 5
Nanotechnology in Biology and Medicine (Charlotte)
Nov. 7-8
Southeastern BIO Investor Forum (Pinehurst)
This newsletter was sent to on Thursday, Sept. 13, 2007. For the latest headlines on North Carolina's biotechnology industry, please visit the news section of our Web site.